GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProMIS Neurosciences Inc (FRA:23J0) » Definitions » Float Percentage Of Total Shares Outstanding

ProMIS Neurosciences (FRA:23J0) Float Percentage Of Total Shares Outstanding : 79.03% (As of May. 02, 2025)


View and export this data going back to 2017. Start your Free Trial

What is ProMIS Neurosciences Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ProMIS Neurosciences's float shares is 25.83 Mil. ProMIS Neurosciences's total shares outstanding is 32.69 Mil. ProMIS Neurosciences's float percentage of total shares outstanding is 79.03%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ProMIS Neurosciences's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ProMIS Neurosciences's Institutional Ownership is 0.03%.

ProMIS Neurosciences Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

ProMIS Neurosciences's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=25.83/32.69
=79.03%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ProMIS Neurosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProMIS Neurosciences Inc (FRA:23J0) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
ALLR PASG CALC FNCH KALA IPA NRXS COCP LPCN NEUP VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
PMN:USA 23J0:Germany
Address
1920 Yonge Street, Suite 200, Toronto, ON, CAN, M4S 3E2
Website
https://www.promisneurosciences.com
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

ProMIS Neurosciences Headlines

No Headlines